Step-by-Step Guide to Treatment of Overactive Bladder (OAB)/Detrusor Overactivity

  • Kate H. Moore
Chapter

Abstract

If a patient has a main complaint of frequency/urgency/nocturia/urge incontinence on history or if urodynamic testing has revealed detrusor overactivity, then bladder training is an essential part of treatment. Most continence clinicians would not prescribe anticholinergic drugs without teaching bladder training first.

Keywords

Mane Imipramine Cystitis Duloxetine Desmopressin 

References

  1. 1.
    Amarenco G, Ismael SS, Even-Scneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Derdraon J. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol. 2003;169:2210–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Awad SA, AlSahrani HM, Gajewski JB, Bourque-Kehoe AA. Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol. 1998;81:569–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Benness C. Vaginal oestradiol for postmenopausal urinary symptoms, a double blind placebo controlled study. In: Proceedings of FIGO. Stockholm; 1992.Google Scholar
  4. 4.
    Bosch J, Groen J. Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. J Urol. 1995;154:504–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Bower WF, Moore KH, Adams R. A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol. 1998;106:2133–6.Google Scholar
  6. 6.
    Brubaker L, Benson JT, Bent A, Clark A, Shott S. Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol. 1997;177:536–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Brubaker L, Richter HE, Visco A, et al. Refractory idiopathic urge urinary incontinence and Botulinum A injection. J Urol. 2008;180:217–22.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Burton G. A randomised cross over trial comparing oxybutynin taken three times a day or taken “when needed”. Neurourol Urodyn. 1994;13:351–2.Google Scholar
  9. 9.
    Chang PL. Urodynamic studies in acupuncture for women with frequency, urgency and dysuria. J Urol. 1988;140:563–6.PubMedGoogle Scholar
  10. 10.
    Cheng Y, Mansfield KJ, Allen W, Walsh CA, Burcher E, Moore KH. Does Adenosine Triphosphate released into voided urodynamic fluid contribute to urgency signaling in women with bladder dysfunction? J Urol. 2010;183:1082–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Cruz F. Vanilloid receptor and detrusor instability. Urology. 2002;59(Suppl 5A):51–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Delaere KP, Debruyne FM, Michiels H, Moonen W. Prolonged bladder distension in the management of the unstable bladder. J Urol. 1980;124:334–6.PubMedGoogle Scholar
  13. 13.
    Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2010;(12):CD005493. DOI:  10.1002/14651858.pub3.
  14. 14.
    Freeman RM. A psychological approach to detrusor instability incontinence in women. Stress Med. 1987;3:9–14.CrossRefGoogle Scholar
  15. 15.
    Frewen WK. The management of urgency and frequency of micturition. Br J Urol. 1980;52:367–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P. Cutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165:1193–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Griffiths D, Tadic SD, Schaefer W, Resnick NM. Cerebral control of the bladder in normal and urge-incontinent women. Neuroimage. 2007;1:1–7. Epub 2007 May 18.CrossRefGoogle Scholar
  18. 18.
    Hasan ST, Robson WA, Pridie AK, Neal DE. Outcome of transcutaneous electrical stimulation in patients with detrusor instability. Neurourol Urodyn. 1994;13:349–50.Google Scholar
  19. 19.
    Herbison G, Arnold E. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev. 2009;(2):CD004202.Google Scholar
  20. 20.
    Herbison P, Hay-Smith J, Ellis G, Moore KH. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Br Med J. 2003;326:841–7.CrossRefGoogle Scholar
  21. 21.
    Jarvis GJ. A controlled trial of bladder drill and drug therapy in the management of detrusor instability. Br J Urol. 1981;53:565–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Kumar V, Cross R, Chess-William R, Chapple C. Recent advances in basic science for overactive bladder. Curr Opin Urol. 2005;15:222–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Leng WW, Blalock HJ, Fredriksson WH, English SF, McGuire EJ. Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol. 1999;161:758–63.PubMedCrossRefGoogle Scholar
  24. 24.
    Moore KH, Gilpin SA, Dixon JS, Richmond DH, Sutherst JR. An increase of presumptive sensory nerves of the urinary bladder in idiopathic detrusor instability. Br J Urol. 1992;70:370–2.PubMedCrossRefGoogle Scholar
  25. 25.
    Morris A, O’Sullivan R, Donkley P, Moore KH. Extracorporeal magnetic stimulation in female detrusor overactivity simultaneous cystometry testing and a randomized sham controlled trial. Eur Urol. 2007;52:876–83.PubMedCrossRefGoogle Scholar
  26. 26.
    Morris AR, Westbrook JI, Moore KH. Idiopathic detrusor over-activity in women – a 5–10 year longitudinal study of outcomes. Neurourol Urodyn. 2003;22:460–2.Google Scholar
  27. 27.
    Nabi G, Cody JD, Ellis G, Hay Smith J, Herbison GP (2009) Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2009. DOI:  10.1002/14651858.CD003781.pub2.
  28. 28.
    Philp T, Shah PJR, Worth PHL. Acupuncture in the treatment of bladder instability. Br J Urol. 1988;61:490–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Ramsden PS, Smith M, Dunn M, Ardran GM. Distention therapy for the unstable bladder: later results including an assessment of repeat distensions. Br J Urol. 1976;48:623–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Scheepens WA, Van Koeveringe GA, DeBie RA, Weil EH, Van Kerrebroeck PE. Long term efficacy and safety results of the two stage implantation techniques in sacral neuromodulation. BJU Int. 2002;90:840–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Shaker HS, Hassouna MM. Sacral nerve root neuromodulation: effective treatment for refractory urge incontinence. J Urol. 1998;159:1516–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Smet P, Moore KH, Jonavicius J. Distribution and colocalisation of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest. 1997;77:37–49.PubMedGoogle Scholar
  33. 33.
    Swami KS, Feneley RC, Hammonds JC, Abrams P. Detrusor myectomy for detrusor overactivity: a minimum 1 year follow-up. Br J Urol. 1998;81:68–72.PubMedCrossRefGoogle Scholar
  34. 34.
    Van der Pal F, Van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome; is maintenance treatment necessary? BJU Int. 2006;97:547–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Kate H. Moore
    • 1
  1. 1.Department Obstetrics & GynaecologySt George HospitalKogarahAustralia

Personalised recommendations